237 related articles for article (PubMed ID: 29102237)
1. Patient and treatment factors associated with survival among pediatric glioblastoma patients: A Surveillance, Epidemiology, and End Results study.
Lam S; Lin Y; Zinn P; Su J; Pan IW
J Clin Neurosci; 2018 Jan; 47():285-293. PubMed ID: 29102237
[TBL] [Abstract][Full Text] [Related]
2. Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.
Perkins SM; Mitra N; Fei W; Shinohara ET
J Neurooncol; 2012 Oct; 110(1):99-104. PubMed ID: 22843450
[TBL] [Abstract][Full Text] [Related]
3. Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis.
Adams H; Adams HH; Jackson C; Rincon-Torroella J; Jallo GI; Quiñones-Hinojosa A
Childs Nerv Syst; 2016 Mar; 32(3):493-503. PubMed ID: 26767842
[TBL] [Abstract][Full Text] [Related]
4. Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis.
Noorbakhsh A; Tang JA; Marcus LP; McCutcheon B; Gonda DD; Schallhorn CS; Talamini MA; Chang DC; Carter BS; Chen CC
J Neurosurg; 2014 Jan; 120(1):31-9. PubMed ID: 24205904
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pediatric Grade II spinal ependymomas: a population-based study.
Lin Y; Jea A; Melkonian SC; Lam S
J Neurosurg Pediatr; 2015 Mar; 15(3):243-9. PubMed ID: 25525932
[TBL] [Abstract][Full Text] [Related]
6. Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010.
Pan IW; Ferguson SD; Lam S
J Clin Neurosci; 2015 Oct; 22(10):1575-81. PubMed ID: 26122381
[TBL] [Abstract][Full Text] [Related]
7. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
[TBL] [Abstract][Full Text] [Related]
8. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
Wen J; Chen W; Zhu Y; Zhang P
BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
[TBL] [Abstract][Full Text] [Related]
9. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.
Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC
World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115
[TBL] [Abstract][Full Text] [Related]
10. Short-term mortality following surgical procedures for the diagnosis of pediatric brain tumors: outcome analysis in 5533 children from SEER, 2004-2011.
Hankinson TC; Dudley RW; Torok MR; Patibandla MR; Dorris K; Poonia S; Wilkinson CC; Bruny JL; Handler MH; Liu AK
J Neurosurg Pediatr; 2016 Mar; 17(3):289-97. PubMed ID: 26588456
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
12. Receipt of brachytherapy is an independent predictor of survival in glioblastoma in the Surveillance, Epidemiology, and End Results database.
Bartek J; Alattar AA; Dhawan S; Ma J; Koga T; Nakaji P; Dusenbery KE; Chen CC
J Neurooncol; 2019 Oct; 145(1):75-83. PubMed ID: 31471790
[TBL] [Abstract][Full Text] [Related]
13. Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis.
Alattar AA; Brandel MG; Hirshman BR; Dong X; Carroll KT; Ali MA; Carter BS; Chen CC
J Neurosurg; 2018 Apr; 128(4):1076-1083. PubMed ID: 28498059
[TBL] [Abstract][Full Text] [Related]
14. Astroblastomas: a Surveillance, Epidemiology, and End Results (SEER)-based patterns of care analysis.
Ahmed KA; Allen PK; Mahajan A; Brown PD; Ghia AJ
World Neurosurg; 2014; 82(1-2):e291-7. PubMed ID: 24141003
[TBL] [Abstract][Full Text] [Related]
15. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
Kozak KR; Moody JS
Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
[TBL] [Abstract][Full Text] [Related]
17. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
18. Choroid plexus tumors in children: a population-based study.
Lam S; Lin Y; Cherian J; Qadri U; Harris DA; Melkonian S; Jea A
Pediatr Neurosurg; 2013; 49(6):331-8. PubMed ID: 25500637
[TBL] [Abstract][Full Text] [Related]
19. Extent of resection and survival for oligodendroglioma: a U.S. population-based study.
Kinslow CJ; Garton ALA; Rae AI; Marcus LP; Adams CM; McKhann GM; Sisti MB; Connolly ES; Bruce JN; Neugut AI; Sonabend AM; Canoll P; Cheng SK; Wang TJC
J Neurooncol; 2019 Sep; 144(3):591-601. PubMed ID: 31407129
[TBL] [Abstract][Full Text] [Related]
20. Optimal extent of resection for glioblastoma according to site, extension, and size: a population-based study in the temozolomide era.
Kim YJ; Lee DJ; Park CK; Kim IA
Neurosurg Rev; 2019 Dec; 42(4):937-950. PubMed ID: 30612289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
